CS logo
small CS logo
Hospital Universiti Sains Malaysia

Kubang Kerian, Kelantan, Malaysia
University hospital in Kota Bharu
Jalan Raja Perempuan Zainab II, Kubang Kerian, 16150 Kota Bharu, Kelantan

About Hospital Universiti Sains Malaysia


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
Universiti Sains Malaysia
22
Boehringer Ingelheim
4
Ministry of Health, Malaysia
2
Takeda
2
Agennix
1
Akamis Bio
1
Bayer
1
Celgene
1
Eli Lilly and Company
1
Gilead Sciences
1
Hospital Universiti Sains Malaysia
1
Total Rows: 19

Clinical Trials at Hospital Universiti Sains Malaysia


During the past decade, Hospital Universiti Sains Malaysia conducted 33 clinical trials. In the 10-year time frame, 33 clinical trials started and 6 clinical trials were completed, i.e. on average, 18.2% percent of trials that started reached the finish line to date. In the past 5 years, 19 clinical trials started and 3 clinical trials were completed. i.e. 15.8% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years66222233116699440000000033330000Started TrialsCompleted Trails201520162017201820192020202120220510
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
VITATOPS: A Study of VITAmins TO Prevent Stroke
1998-11-01
2009-06-01
Completed
8,164
Combination of Gemcitabine and Carboplatin in Metastatic or Recurrent Nasopharyngeal Carcinoma
2008-01-01
2011-05-01
Completed
18
Safety and Efficacy of Talactoferrin in Previously Treated Patients With Non-small Cell Lung Cancer
2008-11-01
2012-08-01
Completed
742
Foscan®-Mediated Photodynamic Therapy Versus Brachytherapy in Patients With Nasopharyngeal Carcinoma
2009-01-01
2011-10-01
Unknown status
66
A Phase 2, Placebo-Controlled Study To Evaluate The Efficacy And Safety Of PF-00489791 In Patients With Type 2 Diabetes And Overt Nephropathy
2010-12-01
2013-08-01
Completed
256
A Clinical Study With MT-102 in Subjects With Cancer Cachexia
2011-04-01
2013-05-01
Completed
87
CAROLINA: Cardiovascular Outcome Study of Linagliptin Versus Glimepiride in Patients With Type 2 Diabetes
2010-11-11
2018-08-21
Completed
6,103
Ranolazine When Added to Glimepiride in Subjects With Type 2 Diabetes Mellitus
2012-01-01
2013-08-01
Completed
431

Rows per page:

1–45 of 45

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "Hospital Universiti Sains Malaysia" #1 sponsor was "Universiti Sains Malaysia" with 22 trials, followed by "Boehringer Ingelheim" with 4 trials sponsored, "Ministry of Health, Malaysia" with 2 trials sponsored, "Takeda" with 2 trials sponsored and "Agennix" with 2 trials sponsored. Other sponsors include 9 different institutions and companies that sponsored additional 19 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Hospital Universiti Sains Malaysia" #1 collaborator was "National Health and Medical Research Council, Australia" with 2 trials as a collaborator, "Ambu A/S" with 1 trials as a collaborator, "Australian and New Zealand Intensive Care Society Clinical Trials Group" with 1 trials as a collaborator, "Eli Lilly and Company" with 1 trials as a collaborator and "International Islamic University Malaysia" with 1 trials as a collaborator. Other collaborators include 5 different institutions and companies that were collaborators in the rest 15 trials.
Created with Highcharts 11.1.0Top Leading SponsorsUniversiti Sains Malaysia: 22Universiti Sains Malaysia: 22Boehringer Ingelheim: 4Boehringer Ingelheim: 4Ministry of Health, Malaysia: 2Ministry of Health, Malaysia: 2Takeda: 2Takeda: 2Agennix: 1Agennix: 1Akamis Bio: 1Akamis Bio: 1Bayer: 1Bayer: 1Celgene: 1Celgene: 1Eli Lilly and Company: 1Eli Lilly and Company: 1Gilead Sciences: 1Gilead Sciences: 1

Created with Highcharts 11.1.0Top CollaboratorsNational Health andMedical ResearchCouncil, Australia: 2National Health andMedical ResearchCouncil, Australia: 2Ambu A/S: 1Ambu A/S: 1Australian and NewZealand Intensive CareSociety Clinical TrialsGroup: 1Australian and NewZealand Intensive CareSociety Clinical TrialsGroup: 1Eli Lilly and Company: 1Eli Lilly and Company: 1International IslamicUniversity Malaysia: 1International IslamicUniversity Malaysia: 1MEDA Pharma GmbH &Co. KG: 1MEDA Pharma GmbH &Co. KG: 1Medical HealthResearch InfrastructureCouncil, Australia: 1Medical HealthResearch InfrastructureCouncil, Australia: 1Merck Sharp & Dohme LLC: 1Merck Sharp & Dohme LLC: 1Ministry of Health, Malaysia: 1Ministry of Health, Malaysia: 1National HeartFoundation, Australia: 1National HeartFoundation, Australia: 1

Clinical Trials Conditions at Hospital Universiti Sains Malaysia


According to Clinical.Site data, the most researched conditions in "Hospital Universiti Sains Malaysia" are "Crohn Disease" (2 trials), "Diabetic Nephropathies" (2 trials), "Difficult Intubation" (2 trials), "Erosive Esophagitis" (2 trials) and "General Anaesthesia" (2 trials). Many other conditions were trialed in "Hospital Universiti Sains Malaysia" in a lesser frequency.

Clinical Trials Intervention Types at Hospital Universiti Sains Malaysia


Most popular intervention types in "Hospital Universiti Sains Malaysia" are "Drug" (28 trials), "Other" (8 trials), "Procedure" (4 trials), "Behavioral" (2 trials) and "Biological" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (10 trials), "BI 685509" (2 trials), "Exercise" (2 trials), "Lansoprazole" (2 trials) and "Lansoprazole Placebo" (2 trials). Other intervention names were less common.

Clinical Trials Genders at Hospital Universiti Sains Malaysia


The vast majority of trials in "Hospital Universiti Sains Malaysia" are 42 trials for "All" genders, 2 trials for "Female" genders and 1 trials for "Male" genders.

Clinical Trials Status at Hospital Universiti Sains Malaysia


Currently, there are NaN active trials in "Hospital Universiti Sains Malaysia". 1 are not yet recruiting, 12 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 25 completed trials in Hospital Universiti Sains Malaysia, undefined suspended trials, and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Hospital Universiti Sains Malaysia, 2 "Phase 1" clinical trials were conducted, 13 "Phase 2" clinical trials and 13 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 14 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhaseNot Applicable: 14Not Applicable: 14Phase 2: 13Phase 2: 13Phase 3: 13Phase 3: 13Phase 1: 2Phase 1: 2Phase 4: 1Phase 4: 1

Created with Highcharts 11.1.0Trials StatusCompleted: 25Completed: 25Recruiting: 12Recruiting: 12Unknown status: 4Unknown status: 4Active, not recruiting: 2Active, not recruiting: 2Not yet recruiting: 1Not yet recruiting: 1Terminated: 1Terminated: 1